EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Triple-negative breast tumors are dependent on mutant p53 for growth and survival

Denada Dibra, Sydney M Moyer, Adel K El-Naggar, Yuan Qi iD, Xiaoping Su, Guillermina Lozano iD

Proceedings of the National Academy of Sciences · 22.08.2023 · 120 (34)

DOI: 10.1073/pnas.2308807120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.08.2023. Verfasst von Denada Dibra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute, EIF | Stand Up To Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The TP53 tumor suppressor gene is mutated early in the majority of patients with triple-negative breast cancer (TNBC). The most frequent TP53 alterations are missense mutations that contribute to tumor aggressiveness. We developed an autochthonous somatic K14-Cre driven TNBC mouse model with p53R172H and p53R245W mutations in which mutant p53 can be toggled on and off genetically while leaving the tumor microenvironment intact and wild-type for p53. These mice develop TNBCs with a median latency of 1 y. Deletion of mutant p53R172H or p53R245W in vivo in these tumors blunts their tumor growth and significantly extends survival of mice. Downstream analyses revealed that deletion of mutant Trp53 activated the cyclic GMP–AMP Synthase–Stimulator of Interferon Genes pathway but did not cause apoptosis implicating other mechanisms of tumor regression. Furthermore, we determined that only tumors with stable mutant p53 are dependent on mutant p53 for growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsTumor Suppressor Protein p53AnimalsHumansMiceGenes, p53MutationMutation, MissenseTumor Microenvironment

Stichwörter der Autor:innen

breast cancermouse modelsmutant p53 stabilitytumor cell vulnerabilities

Substanzen

Tumor Suppressor Protein p53Trp53 protein, mouse

Autor:innen und Institutionen

  • Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Genetics and Epigenetics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

ORCID-Profile: Yuan Qi, Guillermina Lozano

Förderung

  • NCI NIH HHS
  • HHS | NIH | National Cancer Institute
  • EIF | Stand Up To Cancer

Zitieren

APA

Dibra, D., Moyer, S. M., El-Naggar, A. K., Qi, Y., Su, X., & Lozano, G. (2023). Triple-negative breast tumors are dependent on mutant p53 for growth and survival. Proceedings of the National Academy of Sciences, 120(34). https://doi.org/10.1073/pnas.2308807120

Vancouver

Dibra D, Moyer SM, El-Naggar AK, Qi Y, Su X, Lozano G. Triple-negative breast tumors are dependent on mutant p53 for growth and survival. Proceedings of the National Academy of Sciences. 2023;120(34). doi:10.1073/pnas.2308807120

BibTeX
@article{Dibra2023,
  author = {Dibra, Denada and Moyer, Sydney M and El-Naggar, Adel K and Qi, Yuan and Su, Xiaoping and Lozano, Guillermina},
  title = {Triple-negative breast tumors are dependent on mutant p53 for growth and survival},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {34},
  doi = {10.1073/pnas.2308807120}
}
Kostenlos starten →